Výsledky vyhledávání - "SM Schwarzenböck"

Akademický článek

Impact of 68Ga-PSMA PET/CT on radiation treatment planning of prostate cancer patients.

Autor: Bock F; Department of Radiotherapy and Radiation Oncology, Rostock University Medical Center, Rostock, Germany., Frerker B; Department of Radiotherapy and Radiation Oncology, Rostock University Medical Center, Rostock, Germany., Schubert L; Department of Nuclear Medicine, Rostock University Medical Center, Rostock, Germany., Rennau H; Department of Radiotherapy and Radiation Oncology, Rostock University Medical Center, Rostock, Germany., Kurth J; Department of Nuclear Medicine, Rostock University Medical Center, Rostock, Germany., Krause BJ; Department of Nuclear Medicine, Rostock University Medical Center, Rostock, Germany., Hildebrandt G; Department of Radiotherapy and Radiation Oncology, Rostock University Medical Center, Rostock, Germany., Schwarzenböck SM; Department of Nuclear Medicine, Rostock University Medical Center, Rostock, Germany.

Publikováno v: Nuklearmedizin. Nuclear medicine [Nuklearmedizin] 2024 Jun; Vol. 63 (3), pp. 199-206. Date of Electronic Publication: 2024 Apr 05.

Zobrazit plný text záznamu

Akademický článek

Patient-Orientated Evaluation of Treatment of Non-Melanoma Skin Cancer with Rhenium-188 Compared to Surgery.

Autor: Krönert MIC; Clinic and Policlinic for Dermatology and Venereology, University Medical Center Rostock, 18057 Rostock, Germany., Schwarzenböck SM; Department of Nuclear Medicine, University Medical Center Rostock, 18057 Rostock, Germany., Kurth J; Department of Nuclear Medicine, University Medical Center Rostock, 18057 Rostock, Germany., Heuschkel M; Department of Nuclear Medicine, University Medical Center Rostock, 18057 Rostock, Germany., Krause BJ; Department of Nuclear Medicine, University Medical Center Rostock, 18057 Rostock, Germany., Emmert S; Clinic and Policlinic for Dermatology and Venereology, University Medical Center Rostock, 18057 Rostock, Germany., Tietze JK; Clinic and Policlinic for Dermatology and Venereology, University Medical Center Rostock, 18057 Rostock, Germany.

Publikováno v: Healthcare (Basel, Switzerland) [Healthcare (Basel)] 2024 Apr 29; Vol. 12 (9). Date of Electronic Publication: 2024 Apr 29.

Zobrazit plný text záznamu

Akademický článek

Presurgical ⁶⁸ Ga-PSMA-11 Positron Emission Tomography for Biochemical Recurrence Risk Assessment: A Follow-up Analysis of a Multicenter Prospective Phase 3 Imaging Trial.

Autor: Djaïleb L; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA. Electronic address: ldjaileb@chu-grenoble.fr., Armstrong WR; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA; ULCA-Caltech Medical Scientist Training Program, David Geffen School of Medicine, Los Angeles, CA, USA., Thompson D; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA., Gafita A; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA., Farolfi A; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA; Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Rajagopal A; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA., Grogan TR; Department of Medicine Statistics Core, University of California Los Angeles, Los Angeles, CA, USA., Nguyen K; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA., Benz MR; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA; Department of Radiological Sciences, University of California Los Angeles, Los Angeles, CA, USA., Hotta M; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA., Barbato F; Department of Nuclear Medicine, Technical University Munich, Klinikum rechts der Isar, Munich, Germany., Ceci F; Division of Nuclear Medicine, IEO European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy., Schwarzenböck SM; Department of Nuclear Medicine, University Medical Centre, Rostock, Germany., Unterrainer M; Department of Radiology, University Hospital, LMU Munich, Munich, Germany., Zacho HD; Department of Nuclear Medicine and Clinical Cancer Research Centre, Aalborg University Hospital, Aalborg, Denmark., Juarez R; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA., Cooperberg M; Department of Urology, University of California San Francisco, San Francisco, CA, USA., Carroll P; Department of Urology, University of California San Francisco, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., Washington S; Department of Urology, University of California San Francisco, San Francisco, CA, USA., Reiter RE; Institute of Urologic Oncology, University of California Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, USA., Eiber M; Department of Nuclear Medicine, Technical University Munich, Klinikum rechts der Isar, Munich, Germany., Herrmann K; Department of Nuclear Medicine, University of Duisburg-Essen, Essen, Germany; German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany., Fendler WP; Department of Nuclear Medicine, University of Duisburg-Essen, Essen, Germany; German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany., Czernin J; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA; Institute of Urologic Oncology, University of California Los Angeles, Los Angeles, CA, USA., Hope TA; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., Calais J; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA; Institute of Urologic Oncology, University of California Los Angeles, Los Angeles, CA, USA.

Publikováno v: European urology [Eur Urol] 2023 Dec; Vol. 84 (6), pp. 588-596. Date of Electronic Publication: 2023 Jul 21.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání